GT Medical Technologies Announces FDA Clearance of Expanded Indication for GammaTile Therapy
GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for GammaTile® Therapy.